Ovid Therapeutics Inc.

SEC 4 · Filed

0001202098-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 26, 2026

Grant, award or other acquisition by PAPADOPOULOS STELIOS

Security
Employee Stock Option (Right to Buy)
Code
A
Shares
65,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-26",
  "direction": "A",
  "exercise_price": "1.65",
  "expiration": "2036-02-25",
  "footnotes": {
    "F1": "The option will vest in full on February 26, 2027, subject to the Reporting Person\u0027s continuous service through such vesting date."
  },
  "owners": [
    {
      "cik": "0001202098",
      "name": "PAPADOPOULOS STELIOS",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "65000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Employee Stock Option (Right to Buy)",
  "shares": "65000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "65000"
}